Literature DB >> 6691837

The potential of the nude mouse xenograft model for the study of head and neck cancer.

B J Braakhuis, G Sneeuwloper, G B Snow.   

Abstract

A total of 130 human head and neck cancers was transplanted subcutaneously in athymic nude mice in order to obtain a series of xenografts. All tumours were derived from previously untreated patients. Initial growth, which was histopathologically confirmed, was observed in 34 cases (26.1%). Serial passages were successful in 12 of 23 cases (52.1%). Of 117 squamous cell carcinomas, 30 (25.9%) showed initial take in the mice. Poorly differentiated squamous cell carcinomas tend to grow more readily than moderately differentiated and well-differentiated ones. Material from metastatic lymph nodes tends to show a higher take than material from primary tumours. In general the tumour-volume doubling time decreased to 4-6 days when the number of passages increased. Histology of the xenografted tumours showed that transplantation had caused no major changes. No macro-, or microscopic signs of metastasis were observed in any of the mice. The implications of this model for fundamental and applied research are discussed.

Entities:  

Mesh:

Year:  1984        PMID: 6691837     DOI: 10.1007/bf00454264

Source DB:  PubMed          Journal:  Arch Otorhinolaryngol        ISSN: 0302-9530


  23 in total

1.  Chromosome analyses of human tumours following hetero-transplantation to the mouse mutant nude.

Authors:  J Visfeldt; C O Povlsen; J Rygaard
Journal:  Acta Pathol Microbiol Scand A       Date:  1972

2.  Human lactic dehydrogenase as a marker for human tumor cells grown in athymic mice.

Authors:  A J Pesce; H C Bubel; L DiPersio; J G Michael
Journal:  Cancer Res       Date:  1977-07       Impact factor: 12.701

3.  In vivo effects of anti-asialo GM1. I. Reduction of NK activity and enhancement of transplanted tumor growth in nude mice.

Authors:  S Habu; H Fukui; K Shimamura; M Kasai; Y Nagai; K Okumura; N Tamaoki
Journal:  J Immunol       Date:  1981-07       Impact factor: 5.422

4.  Expression of metastatic potential of allogenic and xenogeneic neoplasms in young nude mice.

Authors:  N Hanna; I J Fidler
Journal:  Cancer Res       Date:  1981-02       Impact factor: 12.701

5.  The human tumour xenograft--a valid model in experimental chemotherapy?

Authors:  A J Shorthouse; J F Smyth; G G Steel; M Ellison; J Mills; M J Peckham
Journal:  Br J Surg       Date:  1980-10       Impact factor: 6.939

6.  Twenty-three new human tumor lines established in nude mice.

Authors:  J Fogh; T Orfeo; J Tiso; F E Sharkey; J M Fogh; W P Daniels
Journal:  Exp Cell Biol       Date:  1980

7.  Influence of the mouse hepatitis virus (MHV) infection on the growth of human tumors in the athymic mouse.

Authors:  A P Kyriazis; L DiPersio; J G Michael; A J Pesce
Journal:  Int J Cancer       Date:  1979-03-15       Impact factor: 7.396

8.  Human malignant melanoma heterotransplanted to nude mice.

Authors:  C Tropé; J E Johnsson; P Alm; T Landberg; H Olsson; J Wennerberg
Journal:  Neoplasma       Date:  1981       Impact factor: 2.575

9.  Transplantation of human tumors in nude mice.

Authors:  Y Shimosato; T Kameya; K Nagai; S Hirohashi; T Koide; H Hayashi; T Nomura
Journal:  J Natl Cancer Inst       Date:  1976-06       Impact factor: 13.506

10.  Heterotransplantation of human cancers into nude mice: a model system for human cancer chemotherapy.

Authors:  B C Giovanella; J S Stehlin; L J Williams; S S Lee; R C Shepard
Journal:  Cancer       Date:  1978-11       Impact factor: 6.860

View more
  19 in total

Review 1.  Animal models of cholangiocarcinoma.

Authors:  Emilien Loeuillard; Samantha R Fischbach; Gregory J Gores; Sumera Rizvi
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2018-04-05       Impact factor: 5.187

2.  Preclinical antitumor activity of 5-aza-2'-deoxycytidine against human and neck cancer xenografts [corrected].

Authors:  B J Braakhuis; G A van Dongen; M van Walsum; A Leyva; G B Snow
Journal:  Invest New Drugs       Date:  1988-12       Impact factor: 3.850

Review 3.  Modeling head and neck cancer stem cell-mediated tumorigenesis.

Authors:  Alexander T Pearson; Trachette L Jackson; Jacques E Nör
Journal:  Cell Mol Life Sci       Date:  2016-05-05       Impact factor: 9.261

Review 4.  Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches.

Authors:  Giacomo Miserocchi; Chiara Spadazzi; Sebastiano Calpona; Francesco De Rosa; Alice Usai; Alessandro De Vita; Chiara Liverani; Claudia Cocchi; Silvia Vanni; Chiara Calabrese; Massimo Bassi; Giovanni De Luca; Giuseppe Meccariello; Toni Ibrahim; Marco Schiavone; Laura Mercatali
Journal:  J Pers Med       Date:  2022-05-24

5.  Successful in vitro growth of human head and neck cancer after transplantation in nude mice.

Authors:  E C Heinerman; B J Braakhuis; G H Boerrigter; G B Snow
Journal:  Arch Otorhinolaryngol       Date:  1985

6.  Tissue distribution of [18F]-5-fluorouracil in mice: effects of route of administration, strain, tumour and dose.

Authors:  G W Visser; G C Gorree; G J Peters; J D Herscheid
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

7.  An optimized synthesis of 18F-labelled 5-fluorouracil and a reevaluation of its use as a prognostic agent.

Authors:  G W Visser; G C Gorree; B J Braakhuis; J D Herscheid
Journal:  Eur J Nucl Med       Date:  1989

8.  Establishment and characterization of patient tumor-derived head and neck squamous cell carcinoma xenografts.

Authors:  Mukund Seshadri; Mihai Merzianu; Haikuo Tang; Nestor R Rigual; Maureen Sullivan; Thom R Loree; Saurin R Popat; Elizabeth A Repasky; Bonnie L Hylander
Journal:  Cancer Biol Ther       Date:  2009-12-19       Impact factor: 4.742

9.  Organoid reorganization of human tumors under in vitro conditions.

Authors:  P Köpf-Maier; B Zimmermann
Journal:  Cell Tissue Res       Date:  1991-06       Impact factor: 5.249

Review 10.  Xenograft models of head and neck cancers.

Authors:  Daisuke Sano; Jeffrey N Myers
Journal:  Head Neck Oncol       Date:  2009-08-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.